Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001771317-19-000001
Filing Date
2019-03-20
Accepted
2019-03-20 14:56:35
Documents
1
Period of Report
2018-10-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2540
  Complete submission text file 0001771317-19-000001.txt   3998
Mailing Address 11601 WILSHIRE BLVD. SUITE 1100 LOS ANGELES CA 90025
Business Address 11601 WILSHIRE BLVD. SUITE 1100 LOS ANGELES CA 90025 312-283-5793
BIOVIE INC. (Issuer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11601 WILSHIRE BLVD. #100 LOS ANGELES CA 90025
Business Address
KIM JOANNE WENDY (Reporting) CIK: 0001771317 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55292 | Film No.: 19694511